139 related articles for article (PubMed ID: 11041228)
21. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
22. Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception.
Galant C; Vekemans M; Lemoine P; Kokorine I; Twagirayezu P; Henriet P; Picquet C; Rigot V; Eeckhout Y; Courtoy PJ; Marbaix E
J Clin Endocrinol Metab; 2000 Dec; 85(12):4827-34. PubMed ID: 11134150
[TBL] [Abstract][Full Text] [Related]
23. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
Goodger AM; Rogers PA; Affandi B
Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
[TBL] [Abstract][Full Text] [Related]
24. The measurement of endometrial perfusion in norplant users: a pilot study.
Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
[TBL] [Abstract][Full Text] [Related]
25. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
Galant C; Berlière M; Dubois D; Verougstraete JC; Charles A; Lemoine P; Kokorine I; Eeckhout Y; Courtoy PJ; Marbaix E
Am J Pathol; 2004 Jul; 165(1):83-94. PubMed ID: 15215164
[TBL] [Abstract][Full Text] [Related]
26. Management of irregular uterine bleeding and spotting associated with Norplant.
Archer DF; Philput CA; Weber ME
Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
[TBL] [Abstract][Full Text] [Related]
27. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?
Vincent AJ; Zhang J; Ostör A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
Hum Reprod; 2002 May; 17(5):1189-98. PubMed ID: 11980737
[TBL] [Abstract][Full Text] [Related]
28. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
Wang G; Zheng S; Fan Z
Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
[TBL] [Abstract][Full Text] [Related]
29. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
[TBL] [Abstract][Full Text] [Related]
30. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives.
Vincent AJ; Salamonsen LA
Hum Reprod; 2000 Aug; 15 Suppl 3():135-43. PubMed ID: 11041229
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of cathepsin D in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle.
Lau TM; Affandi B; Rogers PA
Mol Hum Reprod; 1996 Apr; 2(4):233-7. PubMed ID: 9238685
[TBL] [Abstract][Full Text] [Related]
32. Non-human primate models; artificial menstrual cycles, endometrial matrix metalloproteinases and s.c. endometrial grafts.
Brenner RM; Rudolph L; Matrisian L; Slayden OD
Hum Reprod; 1996 Oct; 11 Suppl 2():150-64. PubMed ID: 8982757
[TBL] [Abstract][Full Text] [Related]
33. Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
Wonodirekso S; Hadisaputra W; Affandi B; Siregar B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():144-9. PubMed ID: 8982756
[TBL] [Abstract][Full Text] [Related]
34. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
35. Endometrial biopsy collection from women receiving Norplant.
Hadisaputra W; Affandi B; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():31-4. PubMed ID: 8982743
[TBL] [Abstract][Full Text] [Related]
36. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
Hickey M; Dwarte D; Fraser IS
Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors.
Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA
J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831
[TBL] [Abstract][Full Text] [Related]
38. Progesterone receptor in Norplant endometrium.
Lau TM; Witjaksono J; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
[TBL] [Abstract][Full Text] [Related]
39. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
Rogers PA; Au CL; Affandi B
Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
[TBL] [Abstract][Full Text] [Related]
40. A review of the endometrial changes in Norplant users.
Wan LS
Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
